Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "OTC"

140 News Found

Cipla Health signs agreement to acquire Endura Mass
News | July 15, 2022

Cipla Health signs agreement to acquire Endura Mass

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.


ALPLA acquires Polish packaging manufacturer APON
News | July 08, 2022

ALPLA acquires Polish packaging manufacturer APON

The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019


Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
News | June 21, 2022

Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications

It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.


CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare
News | June 15, 2022

CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare

The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger


USFDA approves Omeprazole capsules to prevent heartburn
Drug Approval | May 27, 2022

USFDA approves Omeprazole capsules to prevent heartburn

Perrigo expects to launch Omeprazole Minis later this year


Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania
News | May 27, 2022

Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in Romania

The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential


Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek
Hospitals | May 11, 2022

Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek

The company also raised Rs 270 crore investment from Temasek in 2019


Aleor Dermaceuticals receives USFDA approval for Docosanol Cream
Drug Approval | May 04, 2022

Aleor Dermaceuticals receives USFDA approval for Docosanol Cream

Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA